Literature DB >> 17656369

Atrial glutathione content, calcium current, and contractility.

Cynthia A Carnes1, Paul M L Janssen, Mary L Ruehr, Hitomi Nakayama, Tomohiro Nakayama, Hannelore Haase, John Anthony Bauer, Mina K Chung, Ian M Fearon, A Marc Gillinov, Robert L Hamlin, David R Van Wagoner.   

Abstract

Atrial fibrillation (AF) is characterized by decreased L-type calcium current (I(Ca,L)) in atrial myocytes and decreased atrial contractility. Oxidant stress and redox modulation of calcium channels are implicated in these pathologic changes. We evaluated the relationship between glutathione content (the primary cellular reducing moiety) and I(Ca,L) in atrial specimens from AF patients undergoing cardiac surgery. Left atrial glutathione content was significantly lower in patients with either paroxysmal or persistent AF relative to control patients with no history of AF. Incubation of atrial myocytes from AF patients (but not controls) with the glutathione precursor N-acetylcysteine caused a marked increase in I(Ca,L). To test the hypothesis that glutathione levels were mechanistically linked with the reduction in I(Ca,L), dogs were treated for 48 h with buthionine sulfoximine, an inhibitor of glutathione synthesis. Buthionine sulfoximine treatment resulted in a 24% reduction in canine atrial glutathione content, a reduction in atrial contractility, and an attenuation of I(Ca,L) in the canine atrial myocytes. Incubation of these myocytes with exogenous glutathione also restored I(Ca,L) to normal or greater than normal levels. To probe the mechanism linking decreased glutathione levels to down-regulation of I(Ca), the biotin switch technique was used to evaluate S-nitrosylation of calcium channels. S-Nitrosylation was apparent in left atrial tissues from AF patients; the extent of S-nitrosylation was inversely related to tissue glutathione content. S-Nitrosylation was also detectable in HEK cells expressing recombinant human cardiac calcium channel subunits following exposure to nitrosoglutathione. S-Nitrosylation may contribute to the glutathione-sensitive attenuation of I(Ca,L) observed in AF.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17656369     DOI: 10.1074/jbc.M704893200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  Dynamic denitrosylation via S-nitrosoglutathione reductase regulates cardiovascular function.

Authors:  Farideh Beigi; Daniel R Gonzalez; Khalid M Minhas; Qi-An Sun; Matthew W Foster; Shakil A Khan; Adriana V Treuer; Raul A Dulce; Robert W Harrison; Roberto M Saraiva; Courtney Premer; Ivonne Hernandez Schulman; Jonathan S Stamler; Joshua M Hare
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-24       Impact factor: 11.205

2.  Attenuated response of L-type calcium current to nitric oxide in atrial fibrillation.

Authors:  Nadiia Rozmaritsa; Torsten Christ; David R Van Wagoner; Hannelore Haase; Johannes-Peter Stasch; Klaus Matschke; Ursula Ravens
Journal:  Cardiovasc Res       Date:  2013-12-12       Impact factor: 10.787

3.  Chronic heart failure and the substrate for atrial fibrillation.

Authors:  Arun Sridhar; Yoshinori Nishijima; Dmitry Terentyev; Mahmood Khan; Radmila Terentyeva; Robert L Hamlin; Tomohiro Nakayama; Sandor Gyorke; Arturo J Cardounel; Cynthia A Carnes
Journal:  Cardiovasc Res       Date:  2009-06-30       Impact factor: 10.787

Review 4.  Enzymatic mechanisms regulating protein S-nitrosylation: implications in health and disease.

Authors:  Puneet Anand; Jonathan S Stamler
Journal:  J Mol Med (Berl)       Date:  2012-02-24       Impact factor: 4.599

Review 5.  Human atrial fibrillation: insights from computational electrophysiological models.

Authors:  Donald M Bers; Eleonora Grandi
Journal:  Trends Cardiovasc Med       Date:  2011-07       Impact factor: 6.677

6.  Association between oxidative stress and atrial fibrillation.

Authors:  Ayman Samman Tahhan; Pratik B Sandesara; Salim S Hayek; Ayman Alkhoder; Kaavya Chivukula; Muhammad Hammadah; Heval Mohamed-Kelli; Wesley T O'Neal; Matthew Topel; Nima Ghasemzadeh; Yi-An Ko; Hiroshi Aida; Mazen Gafeer; Laurence Sperling; Viola Vaccarino; Yongliang Liang; Dean P Jones; Arshed A Quyyumi
Journal:  Heart Rhythm       Date:  2017-07-27       Impact factor: 6.343

Review 7.  Electrophysiological and molecular mechanisms of paroxysmal atrial fibrillation.

Authors:  Stanley Nattel; Dobromir Dobrev
Journal:  Nat Rev Cardiol       Date:  2016-08-04       Impact factor: 32.419

Review 8.  Antioxidant therapies for the management of atrial fibrillation.

Authors:  Tong Liu; Panagiotis Korantzopoulos; Guangping Li
Journal:  Cardiovasc Diagn Ther       Date:  2012-12

Review 9.  Atrial Ca2+ signaling in atrial fibrillation as an antiarrhythmic drug target.

Authors:  Dobromir Dobrev
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-09-26       Impact factor: 3.000

Review 10.  There goes the neighborhood: pathological alterations in T-tubule morphology and consequences for cardiomyocyte Ca2+ handling.

Authors:  William E Louch; Ole M Sejersted; Fredrik Swift
Journal:  J Biomed Biotechnol       Date:  2010-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.